Table 2. Tolerability assessment of wilate infusions by reason for administration.
| Reason for administration | Tolerability assessment (patient) | Total number of infusions, n | ||
|---|---|---|---|---|
| Excellent, n (%) | Satisfactory, n (%) | Unsatisfactory, n (%) | ||
| Prophylaxis | 5,393 (98.1) | 97 (1.8) | 4 (0.1) | 5,494 |
| Bleeding | 654 (92.2) | 55 (7.8) | 0 (0) | 709 |
| Surgery | 42 (95.4) | 1 (2.3) | 1 (2.3) | 44 b |
| Menstruation | 127 (78.4) | 35 (21.6) | 0 (0) | 162 |
| Prevention a | 38 (43.2) | 50 (56.8) | 0 (0) | 88 |
| Total | 6,254 (96.2) | 238 (3.7) | 5 (0.1) | 6,497 |
Abbreviation: n , number of infusions.
Note: For infusions administered for surgeries, only those with available tolerability assessments are presented. Any one wilate infusion may have been administered for more than one reason (e.g., for the treatment of a bleeding episode and menstruation).
a
Administered for the purpose of preventing recurrent BEs in patients undergoing on-demand treatment or surgery only.
b
Investigator rating.